Search

Equine Protozoal Myeloencephalitis (EPM) is an infectious disease whose main agent is the protozoan Sarcocystis neurona. The parasite affects the central nervous system of horses and can cause neurological alterations like ataxia, paresis, muscle atrophy and changes in mental status. With wide distribution in the national territory, it is important that this disease is part of the differential diagnosis in animals of equine species, since equines with this disease can present from discrete signs, such as a slight decrease in performance, to serious neurological signs. That is why the veterinarian must understand its characteristics and effective diagnostic methods for its identification. A five-year-old Brazilian Sport Horse mare was attended in the city of Belo Horizonte, Minas Gerais, with a history of atrophy in the lumbar region and rump. Also, the presence of opossums on the farm where the animal lived was reported. In neurological examination, grade 2 motor incoordination was detected. The SAG ELISA test was performed, and a positive result was obtained. All findings and the positive test result corroborate the diagnosis of EPM, which led to the recommended treatment, and visible clinical improvement. The aim of this paper is to report a clinical case of EPM in a mare in the city of Belo Horizonte, Minas Gerais, Brazil, taking into account the importance of knowledge of the epidemiological, clinical, diagnostic and therapeutic aspects of disease. [ABSTRACT FROM AUTHOR]

Paracoccidioidomycosis (PCM) is a systemic mycosis endemic to Latin America caused by thermodimorphic fungi of the genus Paracoccidioides. In the last two decades, enhanced understanding of the phylogenetic species concept and molecular variations has led to changes in this genus' taxonomic classification. Although the impact of the new species on clinical presentation and treatment remains unclear, they can influence diagnosis when serological methods are employed. Further, although the infection is usually acquired in rural areas, the symptoms may manifest years or decades later when the patient might be living in the city or even in another country outside the endemic region. Brazil accounts for 80% of PCM cases worldwide, and its incidence is rising in the northern part of the country (Amazon region), owing to new settlements and deforestation, whereas it is decreasing in the south, owing to agriculture mechanization and urbanization. Clusters of the acute/subacute form are also emerging in areas with major human intervention and climate change. Advances in diagnostic methods (molecular and immunological techniques and biomarkers) remain scarce, and even the reference center's diagnostics are based mainly on direct microscopic examination. Classical imaging findings in the lungs include interstitial bilateral infiltrates, and eventually, enlargement or calcification of adrenals and intraparenchymal central nervous system lesions are also present. Besides itraconazole, cotrimoxazole, and amphotericin B, new azoles may be an alternative when the previous ones are not tolerated, although few studies have investigated their use in treating PCM. [ABSTRACT FROM AUTHOR]